Published in Curr HIV Res on March 01, 2009
HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology (2011) 1.17
Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy. Cell Biosci (2012) 0.81
HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome. PLoS One (2010) 0.81
Molecular characterization of HIV-1 genome in fission yeast Schizosaccharomyces pombe. Cell Biosci (2015) 0.79
Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma. PLoS One (2010) 0.76
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature (2008) 14.99
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology (1995) 14.30
The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci (2004) 7.92
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A (1994) 7.85
GSK3 takes centre stage more than 20 years after its discovery. Biochem J (2001) 7.74
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol (1995) 7.57
Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J (2001) 4.74
The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol (1995) 4.42
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity (2005) 3.70
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol (1995) 3.69
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61
Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog (2008) 3.27
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol (2006) 3.27
Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J (1992) 3.25
The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol (2006) 3.17
Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol (1995) 2.88
Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol (1997) 2.82
HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev (1998) 2.82
Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog (2007) 2.75
Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog (2008) 2.72
Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc Natl Acad Sci U S A (2007) 2.64
HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat Med (1997) 2.56
Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. J Virol (2002) 2.50
Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J Virol (2003) 2.46
Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst (1993) 1.99
Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science (1998) 1.83
Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol (2001) 1.82
Origin of vpx in lentiviruses. Nature (1990) 1.73
Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem (1995) 1.58
The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc Natl Acad Sci U S A (1995) 1.53
Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J Mol Biol (2000) 1.44
A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci U S A (1995) 1.43
Transcriptional regulation and binding of heat shock factor 1 and heat shock factor 2 to 32 human heat shock genes during thermal stress and differentiation. Cell Stress Chaperones (2004) 1.38
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci U S A (2003) 1.38
Stress-specific activation and repression of heat shock factors 1 and 2. Mol Cell Biol (2001) 1.37
Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen (2007) 1.33
Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex. Exp Cell Res (2000) 1.27
Complex evolutionary history of primate lentiviral vpr genes. Virology (1998) 1.26
The life and death of translation elongation factor 2. Biochem Soc Trans (2006) 1.23
Regulation of heat shock factor in Schizosaccharomyces pombe more closely resembles regulation in mammals than in Saccharomyces cerevisiae. Mol Cell Biol (1991) 1.20
Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol (1999) 1.12
Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J Virol (2004) 1.11
Small heat shock protein suppression of Vpr-induced cytoskeletal defects in budding yeast. Mol Cell Biol (1997) 1.09
Human immunodeficiency virus type 1 DNA nuclear import and integration are mitosis independent in cycling cells. J Virol (2003) 1.08
Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1. Virology (1997) 1.08
Schizosaccharomyces pombe: a model for molecular studies of eukaryotic genes. DNA Cell Biol (1995) 1.05
Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection. DNA Cell Biol (2002) 1.01
Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J Biol Chem (1998) 1.01
Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. Virus Res (2000) 1.01
Extracellular addition of a domain of HIV-1 Vpr containing the amino acid sequence motif H(S/F)RIG causes cell membrane permeabilization and death. Mol Microbiol (1996) 1.01
Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages. J Virol (2003) 1.00
Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1. J Biol Chem (2007) 0.99
Human major HSP70 protein complements the localization and functional defects of cytoplasmic mutant SV40 T antigen in Swiss 3T3 mouse fibroblast cells. Genes Dev (1991) 0.98
Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J Acquir Immune Defic Syndr (2000) 0.95
HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints. Front Biosci (2002) 0.94
HIV-1 Vpr and anti-inflammatory activity. DNA Cell Biol (2004) 0.93
Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophages. Blood (2004) 0.92
Yeast perspectives on HIV-1 VPR. Front Biosci (2000) 0.90
Suppressive effect of elongation factor 2 on apoptosis induced by HIV-1 viral protein R. Apoptosis (2006) 0.89
HIV-1 Vpr-induced cell death in Schizosaccharomyces pombe is reminiscent of apoptosis. Cell Res (2008) 0.87
Anti-vpr activities of heat shock protein 27. Mol Med (2007) 0.87
Anti-Vpr activity of a yeast chaperone protein. J Virol (2004) 0.86
Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1. Proc Natl Acad Sci U S A (2003) 0.86
Determinants for lentiviral infection of non-dividing cells. Somat Cell Mol Genet (2001) 0.85
Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection. Infect Dis Obstet Gynecol (1999) 0.84
Effect of cell cycle arrest on the activity of nucleoside analogues against human immunodeficiency virus type 1. J Virol (2005) 0.84
Genetic selection of peptide inhibitors of human immunodeficiency virus type 1 Vpr. J Biol Chem (2002) 0.83
HIV-1 viral protein R compromises cellular immune function in vivo. Int Immunol (2002) 0.83
Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25. J Virol (2007) 0.83
Antagonistic interaction of HIV-1 Vpr with Hsf-mediated cellular heat shock response and Hsp16 in fission yeast (Schizosaccharomyces pombe). Retrovirology (2007) 0.82
Altered constitutive and stress-regulated heat shock protein 27 expression in HIV type 1-infected cell lines. AIDS Res Hum Retroviruses (1995) 0.82
Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2. AIDS Res Hum Retroviruses (1995) 0.79
Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol (2006) 3.48
Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol (2006) 2.45
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol (2002) 1.97
Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem (2002) 1.96
HIV infection and high density lipoprotein metabolism. Atherosclerosis (2007) 1.62
Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res (2007) 1.57
The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol (2009) 1.55
Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res (2007) 1.51
Dealing with the family: CD147 interactions with cyclophilins. Immunology (2006) 1.46
Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology (2006) 1.39
Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis (2010) 1.34
Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A. J Mol Biol (2009) 1.21
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program. Am J Med Genet C Semin Med Genet (2014) 1.19
Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol Pharmacol (2010) 1.12
HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux. J Lipid Res (2012) 1.11
Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J Virol (2004) 1.11
HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis. PLoS Med (2007) 1.10
Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo. J Lipid Res (2008) 1.08
Single-cell fluorescence imaging using metal plasmon-coupled probe 2: single-molecule counting on lifetime image. Nano Lett (2008) 1.07
Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology (2012) 1.04
Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci U S A (2002) 1.02
Nature, nurture and HIV: The effect of producer cell on viral physiology. Virology (2013) 1.02
Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection. AIDS Res Hum Retroviruses (2002) 1.00
Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1. J Biol Chem (2007) 0.99
Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain. J Biol Chem (2005) 0.98
Two independent epidemics of HIV in Maryland. J Acquir Immune Defic Syndr (2010) 0.97
Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. Retrovirology (2010) 0.97
Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication. Mol Med (2012) 0.96
Fluorescent avidin-bound silver particle: a strategy for single target molecule detection on a cell membrane. Anal Chem (2009) 0.95
HIV-1 viral protein R (Vpr) & host cellular responses. Indian J Med Res (2005) 0.94
Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation. Biochemistry (2010) 0.93
HIV-1 transforms the monocyte plasma membrane proteome. Cell Immunol (2009) 0.93
Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophages. Blood (2004) 0.92
ATM-mediated transcriptional elevation of prion in response to copper-induced oxidative stress. J Biol Chem (2008) 0.91
Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection. Biochem Biophys Res Commun (2012) 0.91
Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. Cell Res (2005) 0.91
The role of different regions of ATP-binding cassette transporter A1 in cholesterol efflux. Biochemistry (2007) 0.89
Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation. Virol J (2008) 0.87
Anti-vpr activities of heat shock protein 27. Mol Med (2007) 0.87
The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study. Atherosclerosis (2013) 0.87
HIV-1 Vpr-induced cell death in Schizosaccharomyces pombe is reminiscent of apoptosis. Cell Res (2008) 0.87
Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells. J Virol (2005) 0.87
CD147 stimulates HIV-1 infection in a signal-independent fashion. Biochem Biophys Res Commun (2007) 0.86
Anti-Vpr activity of a yeast chaperone protein. J Virol (2004) 0.86
Enhanced fluorescence images for labeled cells on silver island films. Langmuir (2008) 0.86
Detection of CXCR4 receptors on cell surface using a fluorescent metal nanoshell. J Biomed Opt (2011) 0.85
Interactions of HIV-1 viral protein R with host cell proteins. Adv Pharmacol (2007) 0.85
Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein. J Virol (2005) 0.85
Direct observation to chemokine receptor 5 on T-lymphocyte cell surface using fluorescent metal nanoprobes. Biochem Biophys Res Commun (2010) 0.84
The level of CD147 expression correlates with cyclophilin-induced signalling and chemotaxis. BMC Res Notes (2011) 0.83
Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25. J Virol (2007) 0.83
Dividing roles of prion protein in staurosporine-mediated apoptosis. Biochem Biophys Res Commun (2006) 0.82
Antagonistic interaction of HIV-1 Vpr with Hsf-mediated cellular heat shock response and Hsp16 in fission yeast (Schizosaccharomyces pombe). Retrovirology (2007) 0.82
Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy. Cell Biosci (2012) 0.81
HIV-1 infection of macrophages induces retention of cholesterol transporter ABCA1 in the endoplasmic reticulum. AIDS Res Hum Retroviruses (2014) 0.81
Strategies to inhibit viral protein nuclear import: HIV-1 as a target. Biochim Biophys Acta (2010) 0.81
Prion infection impairs cholesterol metabolism in neuronal cells. J Biol Chem (2013) 0.81
HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome. PLoS One (2010) 0.81
Long-term changes of serum chemokine levels in vaccinated military personnel. BMC Immunol (2006) 0.81
From molecular diagnostics to personalized testing. Pharmacogenomics (2007) 0.80
Reverse transcription complex: the key player of the early phase of HIV replication. Future Virol (2007) 0.80
Inhibition of HIV-1 nuclear import via schiff base formation with arylene bis(methylketone) compounds. Bioorg Med Chem Lett (2002) 0.79
Update on the laboratory diagnosis and monitoring of HIV infection. Cell Res (2005) 0.78
Oxidative stress induced by HIV-1 F34IVpr in Schizosaccharomyces pombe is one of its multiple functions. Exp Mol Pathol (2009) 0.78
APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication. Retrovirology (2008) 0.78
Nuclear translocation as a novel target for anti-HIV drugs. Expert Rev Anti Infect Ther (2005) 0.77
Interaction of pathogens with host cholesterol metabolism. Curr Opin Lipidol (2014) 0.77
Functional analysis of Leishmania major cyclophilin. Int J Parasitol (2007) 0.77
Direct observation of chemokine receptors 5 on T-lymphocyte cell surfaces using fluorescent metal nanoprobes 2: Approximation of CCR5 populations. Biochem Biophys Res Commun (2011) 0.76
Zeocin for selection of bleMX6 resistance in fission yeast. Biotechniques (2011) 0.76
Antiretroviral compounds and cholesterol efflux from macrophages. Atherosclerosis (2009) 0.76
B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity. Virology (2002) 0.76
beta-Chemokine production in CD40L-stimulated monocyte-derived macrophages requires activation of MAPK signaling pathways. Cytokine (2003) 0.76
Commentary on "Prevalence and evolution of drug resistance HIV-1 variants in Henan, China". Cell Res (2005) 0.75
Fluorescent metal nanoshell and CK19 detection on single cell image. Biochem Biophys Res Commun (2011) 0.75
Regulation of unbalanced redox homeostasis induced by the expression of wild-type HIV-1 viral protein R (NL4-3Vpr) in fission yeast. Acta Biol Hung (2015) 0.75
Metal plasmon-coupled fluorescence imaging and label free coenzyme detection in cells. Biochem Biophys Res Commun (2012) 0.75
Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse. Curr HIV Res (2016) 0.75
Unsung hero Robert C. Gallo. Science (2009) 0.75
A multiplex real-time PCR method for quantification of BK and JC polyomaviruses in renal transplant patients. Diagn Mol Pathol (2010) 0.75
An editorial overview: HIV/AIDS in China. Cell Res (2005) 0.75